CRISPR/CAS9 Technologies

21Citations
Citations of this article
103Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/CRISPR-associated protein (Cas) pathway is revolutionizing biological research. Modifications to this primitive prokaryotic immune system now enable scientists to efficiently edit DNA or modulate gene expression in living eukaryotic cells and organisms. Thus, many laboratories can now perform important experiments that previously were considered scientifically risky or too costly. Here, we describe the components of the CRISPR/Cas system that have been engineered for use in eukaryotes. We also explain how this system can be used to genetically modify cell lines and model organisms, or regulate gene expression in order to search for new participants in biological pathways. © 2017 American Society for Bone and Mineral Research.

Cite

CITATION STYLE

APA

Williams, B. O., & Warman, M. L. (2017). CRISPR/CAS9 Technologies. Journal of Bone and Mineral Research, 32(5), 883–888. https://doi.org/10.1002/jbmr.3086

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free